“Aida Mohammadkhani”

Email: 

IPM Positions

Ph.D. Student, School of Cognitive Sciences
(2012 - 2018 )

Related Papers

1. A. MohammadKhani, J. Fragale, C. Pantazis, H. Bowrey, M. James and G. Jones
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil
Neurobiology of Disease (2019), 9831-9840  [abstract]
2. A. MohammadKhani, M. James, C. Pantazis and G. Aston-Jones
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Brain Research (2019),   [abstract]
3. J. Fragale, K. Porter-Stransky, A. Mohammadkhani, C. Pantazis, M. James and G. Aston-Jones
The role of medial hypothalamus orexin circuits in prescription opioid abuse
( In: SFN 2017)
[abstract]
4. H. Bowrey, M. James, A. Mohammadkhani, M. Omrani, G. Kane and G. Aston-Jones
Chemogenetic activation of a retinal circuit that activates locus coeruleus neurons prevents the development of light-deprivation induced depression-like behavior
( In: SFN 2017)
[abstract]
5. A. Mohammadkhani, C. Pantazis and G. Aston-Jones
Inhibiting orexin-1 receptor signaling in ventral pallidum decreases demand for the opioid remifentanil
( In: SFN 2017)
[abstract]
6. A. Mohammadkhani, H. Azizi and S. Semnanian
The effect of coerulear orexin and dynorphin receptor antagonism on morphine withdrawal induced conditioned place aversion
( In: 2016-S-8536-SFN)
[abstract]
[Back]   
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
scroll left or right